AzTrials
AzTrials

PTSD in Family Members of ICU PatientsOPEN-UNITNCT03846323

Liberalization of Visiting Policies in ICU for Reducing High Risk of Post-traumatic Stress Disorder

A study testing Visiting policies: 24 hours a day, 7 days a week and Restriction of visiting policies < 6 hours in people with PTSD in Family Members of ICU Patients, run by Assistance Publique - Hôpitaux de Paris.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

This was a cluster randomized study of an ICU level intervention to reduce high risk of post-traumatic stress disorder (PTSD) in family members of ICU patients. Participating ICUs had restrictive visiting policies (i.e., <6 hours/day) before randomization. Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
PTSD in Family Members of ICU Patients
What is being tested?
Visiting policies: 24 hours a day, 7 days a week and Restriction of visiting policies < 6 hours
Could I receive a placebo?
No, everyone receives an active treatment
How many people
1,289 participants
Where
No sites listed yet
Study dates
18 Apr 2009to 12 Feb 2018
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Patient and family member > 18 years or older,
  • mechanical ventilation expected for more than 48 h and inclusion between day 3 and 5 from the beginning of mechanical ventilation,
  • patient having a family member speaking and understanding French, and with the ability to visit his/her relative during the ICU stay,
  • patient and his/her relative consenting to participate in the study, or obtention of family consent in case of patient incompetency

Who cannot join

  • Patient without family available or family not speaking or understanding French"

About this study

Official title: Liberalization of Visiting Policies in ICU for Reducing High Risk of Post-traumatic Stress Disorder (PTSD) in Family Members.

This was a cluster randomized study of an ICU level intervention to reduce high risk of post-traumatic stress disorder (PTSD) in family members of ICU patients.

Participating ICUs had restrictive visiting policies (i.e., <6 hours/day) before randomization.

After an observational period and a washout period, participating ICUs were randomized either to maintain their visiting policies or to liberalize their visiting policies (24 hours a day, 7 days a week.)

Read the detailed description

Family members of ICU patients are particularly exposed to anxiety, depressive, acute stress disorder, and posttraumatic stress disorder symptoms (PTSD).

It is currently unknown what type of interventions/ strategies to cope with postintensive care syndrome family would produce the best improvement. Experts suggest that symptoms in family members are potentially amenable to intervention by ICU staff. One intervention to reduce PTSD could be a liberalization of the visiting hours. However, restrictions on visiting hours in the intensive care unit (ICU) are usually adopted worldwide.

Being tested
Visiting policies: 24 hours a day, 7 days a week, Restriction of visiting policies < 6 hours
Keywords
Posttraumatic stress disorder (PTSD), ICU, visiting hours policies
Medical subject headings
Stress Disorders, Post-Traumatic

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Visiting policies: 24 hours a day, 7 days a weekOther

  • Restriction of visiting policies < 6 hoursOther

Study groups in NCT03846323
Study groupRoleWhat they receive
Visiting policies: open 24h/24ExperimentalVisiting policies: 24 hours a day, 7 days a week
Receives: Other: Visiting policies: 24 hours a day, 7 days a week
Restriction of visiting policiesOtherRestriction of visiting policies < 6 hours
Receives: Other: Restriction of visiting policies < 6 hours

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Symptoms related to posttraumatic stress disorder (PTSD)

    Impact event scale (IES). The Impact of Event scale (IES), which assesses symptoms related to post-traumatic stress disorder (PTSD); scores range from 0 (no PTSD-related symptoms) to 75 (severe PTSD-related symptoms).

    Measured: at day-90 from patient's ICU discharge

Secondary outcomes (6)
  1. Beliefs and attitudes of healthcare workers toward visiting hours

    Beliefs and Attitudes toward Visitation in ICU Questionnaire (BAVIQ). Beliefs and attitudes of ICU staff members were recorded at the beginning of period 1 (observation period) and at the end of period 2 (intervention period) using a questionnaire named the Beliefs and Attitudes toward Visitation in ICU Questionnaire (BAVIQ). The "Beliefs" questionnaire contains both positively and negatively formulated questions. To calculate an overall score for nurses 'beliefs, we recoded the responses on the negatively formulated questions. Subsequently, we computed the average score over all the belief items. A score of zero corresponded with beliefs that are strongly opposed to open visitation and a score of 4 corresponded with beliefs that are strongly in favor of open visitation.

    Measured: 120 days

  2. Family member's needs

    Critical Care Family Needs Inventory (CCFNI) Family needs and satisfaction was measured by a modified version of the Critical Care Family Needs Inventory (CCFNI). The satisfaction score was calculated as the sum of the scores on all items; the smallest possible score was 0 (extreme dissatisfaction) and the highest possible score was 14 (extreme satisfaction).

    Measured: At inclusion

  3. Family members' symptoms of anxiety and depression

    Hospital and Anxiety Depression Scale (HADS) The Hospital and Anxiety and Depression Scale (HADS), subscale scores range from 0 (no distress) to 21 (severe distress), HADS subscales scores 5Anxiety and Depression) above 8 were considered to indicate clinically significant symptoms of anxiety or depression.

    Measured: At inclusion and Day-90 from patient's ICU discharge

  4. the proportion of family members with High risk of PTSD occurrence

    Score IES > 30 points

    Measured: At day-90 from patients'ICU discharge

  5. Patients' symptoms of anxiety and depression

    Hospital and Anxiety Depression Scale (HADS) The Hospital and Anxiety and Depression Scale (HADS), subscale scores range from 0 (no distress) to 21 (severe distress), HADS subscales scores (Anxiety and Depression) above 8 were considered to indicate clinically significant symptoms of anxiety or depression.

    Measured: At day-90 from patients'ICU discharge

  6. the proportion of patients with High risk of PTSD occurrence

    Score IES > 30 points

    Measured: At day-90 from patients'ICU discharge

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted19 Feb 2019
  2. Study start18 Apr 2009
  3. Primary completion17 Dec 2013
  4. Study completion12 Feb 2018

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Prevention
Allocation
Randomised
Intervention model
Crossover
Masking
Single blind
Who is masked
Outcomes assessor
Enrolment
1,289 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03846323
Sponsor's protocol ID
AOM08226
Acronym
OPEN-UNIT
Status last verified
May 2018
First submitted
6 Dec 2018
Last updated
19 Feb 2019
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing Visiting policies: 24 hours a day, 7 days a week and Restriction of visiting policies < 6 hours in people with PTSD in Family Members of ICU Patients, run by Assistance Publique - Hôpitaux de Paris.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 19 Feb 2019. Status can change between updates, so confirm with the study contact before making plans.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Symptoms related to posttraumatic stress disorder (PTSD) (time frame: at day-90 from patient's ICU discharge). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 19 Feb 2019.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in